Search

Background: Type-2 diabetes mellitus (T2DM) can have a notable impact on the psychological and physical well-being of individuals, which in turn affects the management of the condition. Men and women experiencing stress and adopting distinct coping strategies. However, research focusing specifically on T2DM in men is still limited. Purpose: The present study intends to investigate the distress and coping strategies adopted by male T2DM outpatients in Malang, East Java, Indonesia. Methods: This study employed a qualitative research design and conducted indepth interviews to 24 male T2DM outpatients. The interview guidelines were formulated using the Indonesian version of the Diabetes Distress Scale (DDS17) questionnaire, which comprised four domains: physician-related distress, emotional burden, regimen-related distress, and interpersonal distress. A thematic analysis was performed to analyze the results gathered during the research and compile them into a final report. Results: The study revealed that individuals diagnosed with T2DM experienced a range of emotional and practical difficulties, including feelings of fear, anxiety, and a lack of understanding. Disease burden, a lack of understanding of both diabetes and healthcare services, difficulties managing their diet, routine medication, financial concerns, and fatigue also contributed to the distress. To cope with distress, the informants identified eight distinct coping strategies. Of these, the most effective strategy was receiving support from family members, followed by acceptance, self management, positive attitude, understanding of their illness, joining the diabetes community, spirituality, and getting more information about T2DM. Conclusion: The findings of this study indicated that men experience eight distinct types of stress and utilise comparable coping strategies associated with T2DM. Emotional distress represents the predominant pressure, while family support constitutes the primary coping strategy. These results are important for nurses and other healthcare professionals in supporting patients. [ABSTRACT FROM AUTHOR]

Introduction: The increased quantities of inflammatory biomarkers such as C-Reactive Proteins (CRP), Tumour Necrosis Factor-α (TNF-α), and Interleukin-6 (IL-6) have been reported to be associated with an increased risk of metabolic syndrome including type 2 diabetes mellitus (T2DM). However, brown rice is an alternative dietary food source that is known to have many health benefits including high fibre content. In addition to fibre, brown rice is also reported to have moderate amounts of proteins, unsaturated lipids, several minerals, and a lot of bioactive substances that are highly beneficial to health. This study aims to prove the role of brown rice dietary intervention in the reduction of inflammatory biomarkers in type 2 diabetes mellitus patients. Design and Methods: This was a cross-sectional study with a post-test conducted on 18 patients with type 2 diabetes mellitus. In the intervention phase I, all type 2 diabetes mellitus patients were given brown rice diet for 3 months and followed by a phase II intervention, in which white rice diet was given to the other group of type 2 diabetes mellitus patients for 3 months. Serum was collected at the end of each intervention stage and then serum for Tumour Necrosis Factor-α, Interleukin-6 and C-Reactive Proteins were analysed by the ELISA method. Statistical analysis of the ttest was conducted in order to determine the differences between the two groups allocated in the study. Results: At the end of the study, it was found that the levels of C-Reactive Protein, Tumour Necrosis Factor-α, and Interleukin-6 after the brown rice intervention was given to type 2 diabetes mellitus patients, it showed a decreasing trend compared to the white rice intervention although not significantly different (p = 0.6, p = 0.63, p = 0.59, respectively). Conclusions: This study concluded that the administration of brown rice dietary intervention to patients with type 2 diabetes mellitus for 3 months was able to reduce Tumour Necrosis Factorα, C-Reactive Proteins, and Interleukin-6 however, the reduction was not significant to influence policy change. [ABSTRACT FROM AUTHOR]